-
公开(公告)号:US06645978B1
公开(公告)日:2003-11-11
申请号:US09787789
申请日:2001-03-23
IPC分类号: A61K900
CPC分类号: A61K31/202 , A61K9/0048 , A61K31/557 , Y10S514/822 , Y10S514/925 , Y10S514/947 , Y10S514/954
摘要: Ophthalmic compositions containing Lipoxin A4 and its analogs and methods of their use for treating dry eve are disclosed.
摘要翻译: 公开了含有Lipoxin A4及其类似物的眼科组合物及其用于治疗干燥前夕的方法。
-
12.
公开(公告)号:US06552084B2
公开(公告)日:2003-04-22
申请号:US09950457
申请日:2001-09-10
IPC分类号: A01N3710
CPC分类号: C07C59/42 , C07C59/46 , C07C2601/02
摘要: Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders are disclosed.
-
13.OPHTHALMIC COMPOSITION WITH NITRIC OXIDE DONOR COMPOUND AND METHOD OF FORMING AND USING SAME 审中-公开
标题翻译: 具有氧化氮化合物的透明组合物及其形成和使用方法公开(公告)号:US20140371267A1
公开(公告)日:2014-12-18
申请号:US14471746
申请日:2014-08-28
IPC分类号: C07D211/94
CPC分类号: C07D211/94 , A61K31/4015 , A61K31/4468 , A61K31/454 , A61K31/496
摘要: The present invention is directed to the provision of ophthalmic compositions such as multi-dose, topical, ophthalmic compositions. The compositions include a nitric oxide (NO) donor compound.
摘要翻译: 本发明涉及提供眼用组合物,例如多剂量,局部,眼用组合物。 组合物包括一氧化氮(NO)供体化合物。
-
公开(公告)号:US07112588B2
公开(公告)日:2006-09-26
申请号:US10808061
申请日:2004-03-24
申请人: Peter G. Klimko , Mark R. Hellberg
发明人: Peter G. Klimko , Mark R. Hellberg
IPC分类号: A61K31/495
CPC分类号: A61K31/407 , A61K31/4015 , Y10S514/912
摘要: Proteasome inhibitors are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
-
公开(公告)号:US06740674B2
公开(公告)日:2004-05-25
申请号:US10150191
申请日:2002-05-17
申请人: Peter G. Klimko , Mark R. Hellberg
发明人: Peter G. Klimko , Mark R. Hellberg
IPC分类号: A61K3146
CPC分类号: A61K31/4015 , A61K31/407 , Y10S514/912
摘要: Proteasome inhibitors are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
摘要翻译: 蛋白酶体抑制剂可用于治疗干眼病和其它需要润湿眼睛的疾病。
-
16.11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension 失效
标题翻译: 用于治疗青光眼和高眼压症的11-Aza前列腺素公开(公告)号:US06211226B1
公开(公告)日:2001-04-03
申请号:US09430533
申请日:1999-10-29
申请人: Mark R. Hellberg , Peter G. Klimko
发明人: Mark R. Hellberg , Peter G. Klimko
IPC分类号: A61K3140
CPC分类号: C07D207/12 , A61K31/40
摘要: 11-aza analogs of PGF2&agr; and methods of their use in treating glaucoma and ocular hypertension are disclosed.
摘要翻译: 公开了PGF2α的11-氮杂类似物及其用于治疗青光眼和高眼压症的方法。
-
17.Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension 失效
标题翻译: 使用某些前列腺素类似物治疗青光眼和高眼压症公开(公告)号:US5807892A
公开(公告)日:1998-09-15
申请号:US480706
申请日:1995-06-07
IPC分类号: A61K31/557 , A61K31/5575 , C07C405/00 , A61K31/695 , A61K31/35 , C07C177/00
CPC分类号: A61K31/5575 , A61K31/557 , C07C405/0016
摘要: Certain prostaglandin analogues are useful in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandin analogues.
摘要翻译: 某些前列腺素类似物可用于治疗青光眼和高眼压症。 还公开了包含这种前列腺素类似物的眼科药物组合物。
-
公开(公告)号:US20110130451A1
公开(公告)日:2011-06-02
申请号:US13022692
申请日:2011-02-08
IPC分类号: A61K31/351 , A61K31/191 , A61K31/22 , A61P27/02
CPC分类号: A61K31/22 , A61K31/047 , A61K31/366
摘要: The topical use of 5,6,7-trihydroxyheptanoic acid and analogs are disclosed for the treatment of dry eye disorders and uveitis.
摘要翻译: 公开了5,6,7-三羟基庚酸及其类似物的局部用途,用于治疗干眼症和葡萄膜炎。
-
公开(公告)号:US07923471B2
公开(公告)日:2011-04-12
申请号:US11268301
申请日:2005-11-07
IPC分类号: A01N37/02 , A01N31/00 , A61K31/22 , A61K31/045
CPC分类号: A61K31/22 , A61K31/047 , A61K31/366
摘要: The topical use of 5,6,7-trihydroxyheptanoic acid and analogs are disclosed for the treatment of dry eye disorders and uveitis.
摘要翻译: 公开了5,6,7-三羟基庚酸及其类似物的局部用途,用于治疗干眼症和葡萄膜炎。
-
20.5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses 有权
标题翻译: 5,6,7-三羟基庚酸和类似物,用于治疗眼部疾病和与过度增生和血管生成反应相关的疾病公开(公告)号:US07879905B2
公开(公告)日:2011-02-01
申请号:US11268968
申请日:2005-11-08
CPC分类号: A61K31/047 , A61K9/0048 , A61K31/20 , A61K31/22 , A61K31/366
摘要: Compositions containing 5,6,7-trihydroxyheptanoic acid and analogs and their use for treating posterior segment ocular diseases and diseases characterized by cellular hyperproliferation or angiogenesis, are disclosed.
摘要翻译: 公开了含有5,6,7-三羟基庚酸及其类似物的组合物及其用于治疗后段眼部疾病和以细胞过度增殖或血管发生为特征的疾病的用途。
-
-
-
-
-
-
-
-
-